Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • VTI vs GSK✓SelectedUSD · GSKVTI vs GSK performance historyLatest closeAs of-0.41%11/13
Stock and ETF performance explorer

VTI vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+938.9%
GSK return
+193.2%
Excess return
+745.7%
Maximum drawdown
-55.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.4%+0.5%-0.9%-0.6%
7D+2.5%+1.1%+1.4%+2.1%
30D-1.5%+6.3%-7.9%-4.2%
3M-3.2%+1.8%-5.0%-4.4%
6M+2.3%+1.7%+0.7%+0.6%
YTD+11.6%+6.5%+5.1%+6.8%
1Y+13.8%+9.5%+4.3%+7.5%
3Y+77.4%+65.3%+12.1%+34.5%
5Y+64.6%+43.7%+20.8%+30.2%
10Y+290.6%+104.1%+186.5%+154.5%
All+938.9%+193.2%+745.7%+392.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling